ALL
Pharma?in?China
Pharma?Experts
Market News
Products Guide
Brand Story
-
AbbVie acquires STING pathway-focused Mavupharma pharmaceutical-technology
July 17, 2019Chicago-based AbbVie has announced its acquisition of Seattle-based oncology drug discovery company Mavupharma. The financial terms of the transaction were not disclosed. -
AbbVie Acquires Mavupharma americanpharmaceuticalreview
July 17, 2019AbbVie has acquired Seattle-based Mavupharma, a privately held biopharmaceutical company focused on novel approaches to target the STING (STimulator of INterferon Genes) pathway for the treatment of cancer. -
Frazier-Backed Mavupharma Scores $20M to Fund STING Program
biospace
November 30, 2017Frazier-backed Mavupharma secures $20M in Series A financing to fund STING program
Pharma Sources Insight January 2025
